RaySearch Laboratories and ADAC Announces Clinical Release of its Intensity Modulated Radiation Therapy (IMRT) Software.
6/13/2001 7:00 AM EST
RaySearch Laboratories and ADAC Announces Clinical Release of its
Intensity Modulated Radiation Therapy (IMRT) Software.
June 13, 2001
ADAC, a Philips Medical Systems company, today announced that it has
released P3IMRT¤, ADAC's Inverse Planning Intensity Modulated Radiation
Therapy (IMRT) software for its Pinnacle3 radiation therapy planning
product.
IMRT is a new technique that allows doctors to more accurately deliver
radiation treatment for their cancer patients. With ADAC's new software,
clinicians can more precisely tailor the treatment dose to match the
target tumor, while sparing the surrounding normal tissue, a process
that was much more difficult with conventional techniques. IMRT enables
the radiation oncologist to escalate the dose to the tumor while
minimizing treatment-related complications. P3IMRT provides
compatibility with all major linear accelerators for precise treatment
delivery using computer-controlled intensity modulation of the radiation
beams. This may ultimately lead to improved local tumor control.
"With the release of P3IMRT, ADAC's Radiation Therapy Products business
continues to provide leading-edge clinical solutions for evolving cancer
management. We believe that the clinical use of P3IMRT will be rapidly
adopted by radiation oncology facilities, and particularly by our large
Pinnacle3 installed base," stated Gary Burbach, CEO of ADAC.
The new software is based on ORBIT (Optimization of Radiation Therapy
Beams by Iterative Techniques), an advanced software tool used to
optimize radiation therapy planning developed at RaySearch Laboratories
AB, based in Stockholm, Sweden. ORBIT provides physicians the potential
to be both more precise and more aggressive than with current
treatments. Future developments will enable the radiation oncologist to
design an optimal treatment plan based on the probability of achieving
complication-free tumor control while accounting for treatment
uncertainties due to organ motion, treatment setup errors, and
variations in patient sensitivity to radiation therapy.
Ian Farmer, vice president and general manager of ADAC's Radiation
Therapy Product business, stated, "Our Pinnacle product has achieved its
market-leading position by providing superior software tools that bring
advanced techniques into clinical practice. P3IMRT is a natural
progression of the treatment planning capabilities provided with the
expanding Pinnacle3 product line. Integrating ORBIT's biological
optimization tools into future software releases will provide radiation
oncology departments with the next generation of advanced inverse IMRT
planning on the Pinnacle platform."
For further information please contact:
Johan Löf, RaySearch Laboratories Tel: + 46 8-545 061 30, e-mail:
Tamara Hausmann, ADAC Laboratories Tel: (408) 468-3123, e-mail:
About RaySearch Laboratories
RaySearch Laboratories is a company based in Stockholm, Sweden.
RaySearch is committed to deliver innovative methods and software for
the improvement of radiation therapy. The company bases its operation on
decades of pioneering research in the field of radiation therapy
optimization performed at the Karolinska Institute in Stockholm.
About ADAC Laboratories
ADAC Laboratories is the world market-share leader in nuclear medicine
and radiation therapy planning systems, and a technology leader in
providing clinical workflow solutions, management information and
knowledge systems to healthcare organizations in North America. ADAC is
headquartered in Milpitas, CA, and its HealthCare Information Systems
Division is located in Houston, Texas.